Compare ARK Genomic Revolution ETF (ARKG) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Verizon Communications Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.56, while Verizon Communications Inc trades at $46.95 (market cap $196.40B). The key difference: Verizon Communications Inc pays a 5.99% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Verizon Communications Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | VZ | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $44.55 | $51.38 |
52-Week Low | $24.02 | $38.40 |
Market Cap | — | $196.40B |
Volume | — | 22,584,735 |
Enterprise Value | — | $383.10B |
Dividend Yield | — | 5.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $44.49, up 0.41% today, with a bullish technical bias from moving averages but overbought RSI signals. The ETF focuses on genomic revolution stocks, with top 10 holdings comprising 59% of assets and a long-term EPS growth rate of 10.7% (Seeking Alpha, 2026-07-28). Recent news highlights biotech sector strength driven by FDA friendliness and AI-driven drug discovery.
Outlook is cautiously optimistic given sector tailwinds, but high concentration and volatility pose risks. The ETF's exposure to small- and mid-cap biotech offers growth potential, yet investors face regulatory and market sentiment shifts. Near-term performance may hinge on broader tech trends and biotech M&A activity.
Verizon (VZ) trades at $46.77, down 0.56% today, with a bullish technical signal from moving averages and a consensus analyst price target of $49.69. The company reported Q2 2026 EPS of $1.30, beating estimates, and maintains strong cash flow with $37.14B from operations in 2025. Recent news highlights partnerships, such as with Fi for pet tech integration, and network initiatives amid competitive pressures from SpaceX's Starlink.
Outlook: VZ offers value with a P/E of 12.31 and a 15.63% ROE, supported by stable dividends. Risks include rising debt to $298.5B in 2025 and revenue stagnation. Opportunities lie in fiber expansion and margin improvements, but investor caution is warranted due to competitive threats and macroeconomic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
